Biologist with a PhD at University of São Paulo Medical School working with induced pluripotent stem cell and its differentiation in cardiomyocytes (2011-2015). Co-founder and CSO of PluriCell Biotech, work with iPSC differentiation into different human cell types (2014...). In the last years, Diogo was the responsible for the internal research at PluriCell Biotech. (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| Cell therapy on the radar |
| La terapia celular en la mira |
| Terapia celular en la mira |
| More itemsLess items |
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Cardiovascular diseases are the biggest cause of death in the world. To date, no cell therapy has become effective because cardiac cells are difficult to obtain and adult stem cells are unable to differentiate into cardiomyocytes. In 2006, the discovery of cellular reprogramming of adult cells to the pluripotent state (iPSC) enabled the creation of cardiomyocytes from pluripotent cells an…
(Only some records are available in English at this moment)
| 3 / 3 | Completed research grants |
| 7 / 5 | Completed scholarships in Brazil |
| 10 / 8 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID
Google Scholar Citations